By Mill Chart
Last update: Oct 18, 2023
In this article we will dive into MEDPACE HOLDINGS INC (NASDAQ:MEDP) as a possible candidate for growth investing. Investors should always do their own research, but we noticed MEDPACE HOLDINGS INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.
ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.
Overall MEDP gets a technical rating of 3 out of 10. In the last year, MEDP was one of the better performers, although we are getting mixed signals now in both the short and medium term time frames.
Our latest full technical report of MEDP contains the most current technical analsysis.
ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.
MEDP gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 61 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues. MEDP is not overvalued while it is showing excellent growth. This is an interesting combination. This makes MEDP very considerable for growth and quality investing!
Our latest full fundamental report of MEDP contains the most current fundamental analsysis.
More ideas for growth investing can be found on ChartMill in our CANSLIM screen.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
MEDPACE HOLDINGS INC
NASDAQ:MEDP (4/25/2024, 7:04:21 PM)
After market: 389.77 0 (0%)389.77
-7.79 (-1.96%)
MEDP stock results show that Medpace Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medpace Hldgs (NASDAQ:MEDP) just reported results for the first quarter of 2024...
Five resilient stocks are setting up or flirting with entries.
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.
Shares of contract research organizations IQVIA Holdings (IQV) and Charles River Laboratories (CRL) gain as their Q4 results exceed expectations. Read more here.